Developmen of Dark Content from Cultural Heritage and Intervention of Public History: Focusing on King Danjong’s Exile Route
SARIM · 30.04.2026 · 96 · 225-260
DOI: 10.20457/sha.96.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift SARIM, online erschienen am 30.04.2026. Verfasst von Dong-uk Im und 1 weiteren Autor:innen.
Abstract (Originalsprache)
This study interprets the exile of King Danjong as a new example of Korean-style dark tourism and examines the possibility of transforming it into public history. Whereas previous studies have focused primarily on modern and contemporary tragedies such as war, massacre, and disaster, this study broadens the scope of dark tourism to include dynastic political tragedy by understanding this incident as a form of dark heritage shaped by the overlapping politics of death, loss, and memory. To this end, it analyzes the spatial characteristics and narrative resources of the Danjong Exile Route and major sites in Yeongwol through the theoretical lenses of dark tourism, cultural memory, sacralization, dissonant heritage. The findings suggest that this Route is both a premodern dark heritage site inscribed with the memory of political violence and a resource with strong potential to develop into public history content that fosters education, commemoration, and reflection.
Zitieren
APA
Im, D., & Lee, K. C. (2026). Developmen of Dark Content from Cultural Heritage and Intervention of Public History: Focusing on King Danjong’s Exile Route. SARIM, 96(0), 225-260. https://doi.org/10.20457/sha.96.9
Vancouver
Im D, Lee KC. Developmen of Dark Content from Cultural Heritage and Intervention of Public History: Focusing on King Danjong’s Exile Route. SARIM. 2026;96(0):225-260. doi:10.20457/sha.96.9
BibTeX
@article{Im2026,
author = {Im, Dong-uk and Lee, Kyu Chul},
title = {Developmen of Dark Content from Cultural Heritage and Intervention of Public History: Focusing on King Danjong’s Exile Route},
journal = {SARIM},
year = {2026},
volume = {96},
number = {0},
pages = {225--260},
doi = {10.20457/sha.96.9}
}
EUVIMED